Arcellx develops novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.
For more details on financing and valuation for Arcellx, register or login.
Already registered? Click here to log in
To read this article and more news on Arcellx, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.